Stanley J Chetcuti MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor, Internal Medicine, University of Michigan Medical School
Request Appointment
1500 E Medical Center Dr3rd Floor Cardiovascular CenterAnn Arbor, MI 48109
Overview of Dr. Chetcuti
Dr. Stanley Chetcuti is a cardiologist in Ann Arbor, MI and is affiliated with multiple hospitals in the area, including Veterans Affairs Ann Arbor Healthcare System and Michigan Medicine. He received his medical degree from University of Malta School of Medicine and has been in practice 27 years. He specializes in structural heart disease and interventional cardiology and is experienced in general cardiology, cardiac catheterization, percutaneous coronary intervention, peripheral vascular disease, and cardiac critical care.
Education & Training
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1995 - 1998
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1995
University of Malta School of MedicineClass of 1990
Certifications & Licensure
MI State Medical License 1999 - 2027
MN State Medical License 1994 - 1996
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Publications & Presentations
PubMed
- A simple clinical scoring model to predict significant left main/three-vessel disease in non-ST elevation acute coronary syndrome: The MADISON score.Rayan Jo Rachwan, Omar Chehab, Rody G Bou Chaaya, Ghassan Daher, Satawart Upadhyay
International Journal of Cardiology. 2026-02-01 - Worse Survival in Transcatheter Aortic Valve Replacement with Untreated Tricuspid Regurgitation: Implications for Surgical Intervention.Jessica Carducci, Whitney Fu, Catherine Wagner, Jack Proebstle, Jessica Woodford
The Journal of Thoracic and Cardiovascular Surgery. 2025-12-19 - 2 citationsEpicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction.Yoran Crum, Dirk J van Veldhuisen, Sanjiv J Shah, Uma Mylavarapu, Mo Hu
JACC. Advances. 2025-12-01
Journal Articles
- Transcatheter Aortic Valve Replacement in Low-Risk Patients with Bicuspid Aortic Valve StenosisJohn K Forrest, Basel Ramlawi, Neal S Kleiman, Stanley J Chetcuti, Hector I Michelena, Abeel A Mangi, Jeffrey A Skiles, Jeffrey J Popma, Michael J Reardon, JAMA Cardiology
- Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic StenosisHarold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect
Lectures
- Making the Case for… - Anatomic Considerations and Optimizing Procedural Outcomes With Case PresentationsCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- Enabling Early TAVR Patient Ambulation Outside the ICU With the Tempo LeadCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- 3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based DiscussionCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Press Mentions
Established TAVR Platforms Evolving for Lifetime ManagementJune 10th, 2024
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TCT 2019September 19th, 2019
Interventional Cardiologist @umichCVC: Low-Risk Approval for #TAVR Is a "Momentous Event" That's "Completely Transformed the Way We Treat People with Aortic Stenosis"August 16th, 2019
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPOFirst Health PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
